drugset / Trial / NCT07418996
Live Double Combined Lactobacillus Capsule for Vaginal Use（IIa）
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a mutilcenter, randomized, double-blind, Metronidazole controlled phase lIa clinical study to evaluate the safety and tolerability of dual - live lactobacilli-containing vaginal capsules for the treatment of Bacterial Vaginosis.
Timeline
- Start
- 2021-05-18
- Primary completion
- 2022-07-04
- Completion
- 2022-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Live double combined lactobacillus capsule | Other / unclassified | 1e+07 unknown | Other |
| Subject | Live double combined lactobacillus capsule | Other / unclassified | 1e+08 unknown | Other |
| Subject | Live double combined lactobacillus capsule | Other / unclassified | 1e+09 unknown | Other |
| Comparator | Metronidazole | Small molecule | — | — |